ACSI:: Enhancing Circulation

Home

Advanced Circulatory
Systems, Inc.
7615 Golden Triangle Drive,
Suite A
Eden Prairie, MN 55344
877-RESQPOD
1-877-737-7763
www.advancedcirculatory.com

ACSI's circulatory enhancer technology improves upon the standard of care provided to patients with a variety of clinical conditions due to low blood flow. Sudden cardiac arrest, traumatic injury, heat stroke and the common faint, for example, all result in states of low

blood flow or perfusion. In each case, a lack of adequate blood flow back to the heart contributes to the low blood pressure. States of low blood flow impair the body's circulatory function, which delivers oxygen to the body's vital organs and removes toxic cellular waste.

ACSI's circulatory enhancer technology uses inspiratory impedance to increase blood flow to the body's vital organs. It is unique in that it enhances the body's biophysical performance without depending upon pharmaceutical or other outside agents. This patented inspiratory impedance technology uses the relationship of the heart, lungs and thorax to increase venous blood return to the heart.

ACSI currently has two Circulatory Enhancement products:

ResQPOD Impedance Threshold Device - for use in patients requiring assisted ventilation, for example, those receiving CPR.
ResQGARD Impedance Threshold Device - for use in spontaneously breathing patients.

The generally cleared indication for the ResQPOD is a temporary increase in blood circulation during emergency care, hospital, clinic and home use. Click here to review the Instructions for Use. Studies are ongoing in the United States to evaluate the
long-term benefit of the ResQPOD for indications related to patients suffering from cardiac arrest, hypotension during dialysis
and severe blood loss.

For more information on completed clinical studies click here. The references on this website are not intended to imply specific outcome-based claims not yet cleared by the US Food and Drug Administration.